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The neuro-ophthalmology of cerebrovascular 
disease is a vast plain of neuro-ophthalmic vistas, 
encompassing virtually all areas of disturbances of 
the eye-brain mechanism. This paper will be re-
stricted to those areas of the neuro-ophthalmology 
of cerebrovascular disease which one might con-
sider advances in its clinical diagnosis and treatment. 
Most practitioners of medical and surgical neu-
rology give little thought to that aspect of medicine 
generally accepted as the ideal approach to any 
disease-prevention. Usually when one is presented 
with an illness of the central nervous system, it 
seems to be a fait accompli. Although prevention 
is by no means new, certain aspects of it qualify 
as advances. There is one advance in cerebrovascu-
lar disease in which prevention plays a significant 
role . This is the recognition and surgical correction 
of atherosclerotic lesions of the extracranial carotid 
system which threaten the patient with that bane 
of antiquity-the "stroke." 
Neuro-ophthalmology, largely by virtue of the 
carotid origin of the ophthalmic artery, plays a 
valuable role in the recognition, evaluation, therapy, 
and prognosis of disease of the extracranial internal 
carotid artery. Even this markedly restricted aspect 
of the neuro-ophthalmology of cerebrovascular dis-
ease is far too extensive to review adequately in 
this paper. I have therefore selected for discussion 
certain aspects of our neuro-ophthalmic approach 
to extracranial carotid disease. Some of these are 
well known; others are less obvious and frequently 
overlooked in our evaluation of patients. They all, 
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however, are important pieces to the puzzle the 
patient may present. A wide variety of afflictions 
of the eye occur by virtue of its arterial dependence 
on the internal carotid artery. It is also logical to 
assume that changes in the distribution of the 
ophthalmic artery may reflect changes taking place 
in other channels of the internal carotid artery-
the middle cerebral, the anterior cerebral, and de-
pending upon anatomic variations, the posterior 
cerebral artery. This paper will discuss these afflic-
tions, those common as well as rare, those well 
recognized, and those frequently overlooked. 
Historically, the recognition of the eye as an 
index of cerebrovascular disease presents an inter-
rupted course. Virchow is credited with the first 
autopsy correlation of ipsilateral blindness with 
carotid thrombosis; Gowers in 1875 demonstrated 
embolization as a source of central retinal artery 
and middle cerebral artery occlusion, resulting in 
monocular blindness and contralateral hemiplegia; 
Chiari followed in 1905 with his identification of 
the carotid bifurcation as a common source of 
atheromatous emboli to the cerebral circulation; in 
1914 Ramsey Hunt emphasized the significance of 
transient symptoms involving the ipsilateral eye and 
contralateral extremities as strong evidence of 
ischemia. Thus by the turn of the century, the 
stage was set for incrimination of the extracranial 
internal carotid artery as a major source of "strokes." 
Embolization was known as a basis for ipsilateral 
eye and contralateral extremity symptoms and 
signs; the carotid bifurcation was known as a source 
of emboli; and transient symptoms were recognized 
as reflections of ischemia-a stroke prodrome or 
warning was discovered. Yet it was for Fisher in 
1951 to rekindle interest in extracranial carotid 
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disease with his emphasis on transient ipsilateral 
visual and contralateral extremity symptoms as pre-
cursors of future strokes. It is this reawakening 
which has led directly to the current advances in 
the medical and surgical neurologic care of extra-
cranial internal carotid disease. 
Amaurosis fugax, "fleeting blindness," has be-
come a household phrase of those involved in the 
diagnosis and care of patients with carotid disease. 
The clinical picture of amaurosis fugax is reasonably 
straightforward. It consists of transient monocular 
painless visual loss. Much has been made of the 
character, duration, mode of onset, and resolution 
of the visual loss. Perhaps too much emphasis has 
been placed on such characteristic patterns as the 
window shade or picket fence effect. As a result, 
we find that many patients we see have already been 
"well educated" by housestaff. The potential patterns 
of visual loss are many. They include 1) an upper 
altitudinal loss of vision, "the window shade"; 2) a 
lower altitudinal loss of vision, "the picket fence"; 
3) a generalized peripheral loss of vision; 4) a total 
blackout of vision; and 5) a central blurring of 
vision. The onset is most frequently abrupt; the 
curtain seldom drops or rises slowly. Occasionally, 
the event is associated with photopsia-crude visual 
hallucinations, usually in the form of showers or 
flecks of light but suggestions of geometric character 
will sometimes be seen. The key factors differentiat-
ing this photopsia from occipital disease and mi-
graine are its clear unilaterality, the patient's age, 
and a detailed analysis of the history, which excludes 
migraine as a consideration and supports amaurosis 
fugax. The event need not be simply a blackout; 
dimming with a sensation of color may occur with 
green and yellow having popularity. In my experi-
ences, color sensation has been uncommon. 
The duration is generally brief, lasting two 
or three minutes, or rarely, five-to-ten minutes . We 
have found a common tendency for patients to 
misjudge the time sequence with frequent exaggera-
tion of the period of visual loss. As this tendency 
to misjudge the duration of visual handicap may 
be bothersome diagnostically, we have adopted a 
simple time confirmation method. It consists of 
instructing the patient that you are going to begin to 
count and he is to assume that this is the onset 
of his visual symptomatology. We encourage the 
patient to "relive" the experience and with the use 
of our verbal clock, determine the average duration 
of visual loss. The rule is to find a duration of from 
one and one-half to two or three minutes despite 
the patient's initial claim of five, ten minutes, or 
longer of impairment. A watch second hand or stop 
watch could also be used; however, the vocal metro-
nome seems helpful. 
Although emphasis has been placed on the 
association of ipsilateral eye and contralateral ex-
tremity signs and symptoms, it should be recognized 
that their actual temporal association is unnecessary 
diagnostically and infrequent clinically. The eye 
symptoms and signs in isolation as evidence of 
cervical internal carotid disease are, in all likelihood, 
far more common than many practitioners realize. 
The work of Lubow and associates at Ohio State 
regarding "retinal strokes" underlines this concept. 
On rare occasions, transient homonymous visual 
impairment may be a reflection of internal carotid 
disease by virtue of a carotid origin of the posterior 
cerebral artery. Correct diagnosis will depend upon 
associated symptoms and signs. 
The precise pathophysiology of these brief 
alterations of visual function continues to excite 
some debate. It seems certain that most are based 
upon emboli of either platelet aggregates or athero-
sclerotic debris. The exact point at which the em-
bolus works its evil is less certain. As will be 
discussed, visible emboli in central retinal arterioles 
must play a role; whether they are the sole inciting 
force is less certain. Emboli to the choroid, not 
apparent clinically, may be important. The role of 
dynamic reduction of blood flow in the production 
of visual symptoms of carotid disease is probably 
small. It does, however, in selected but infrequent 
instances, probably play a significant role. Total 
carotid occlusions obviously cause some transient 
visual symptoms; generally, the symptoms cease 
following the stabilization occurring postocclusiori. 
Our diagnostic evaluation of patients with 
symptoms of transient visual loss consists of the 
careful analysis and integration of the specific physi-
cal signs with the presenting and elicited symptoms. 
Although we have defined amaurosis fugax as 
transient painless monocular visual loss, occasionally, 
residual deficits of vision remain. In addition, a 
number of patients with cervical internal carotid 
disease present not with transient ipsilateral eye 
symptoms but with fixed deficits. 
Needless to say, the diagnostic evaluation of 
all patients with eye symptoms and signs suggesting 
ipsilateral carotid disease must begin with docu-
mentation of visual function-this includes best 
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corrected visual acuity, pupillary reactivity, and 
quantitative visual field evaluation. Although we 
palpate neck vessels, much less than total absence 
of vessel pulsation is lightly regarded. Auscultation 
is considered an important adjunct, with realiza-
tion that bruits at sites other than the suspected 
symptomatic area may be significant. A bruit in 
isolation, however, is of dubious benefit. 
The final, but perhaps most valuable, aspect 
of the neuro-ophthalmic diagnostic evaluation of 
patients suspected of harboring atherosclerotic dis-
ease is the dilated funduscopic examination with the 
recording of retinal artery pressures. If one is for-
tunate enough to be present during an amaurotic 
event, funduscopy may reveal white platelet emboli or 
bright cholesterol plaques passing through the central 
retinal arterioles. As this is a distinctly uncommon 
opportunity, one must usually be satisfied with resi-
due which remains behind-most commonly, bright 
cholesterol material lodged at arteriole bifurcations. 
Hollenhorst, who first recognized the significance of 
retinal emboii in 1961, recorded a 33% incidence of 
these "Hollenhorst plaques" in patients with sympto-
matic cerebrovascular insufficiency. 
Ophthalmodynamometry (ODM) should be 
routinely performed following a thorough fundu-
scopic survey. The technique of ODM was first 
devised by Baillart in 1917 to measure central 
artery pressure. Svien and Hollenhorst popularized 
its use in 1956. One must keep in mind that ODM's 
are not a measurement of absolute pressures. This 
is, by and large, not a disadvantage as their primary 
benefit is a relative comparison of one eye with 
the other. We, as do many others, commonly record 
only the diastolic reading and routinely perform 
the ODM's in the sitting position. Before we con-
sider the asymmetry significant, we require a 15 % 
difference when the readings are below 40 units and 
a 20% difference when the readings are above 40 
units. Any readings below 20 units are considered 
abnormal. The basic mechanism of ODM is the 
simple increase of intraocular pressure to levels 
above the central artery pressure. Needless to say, 
either increased or decreased intraocular tension 
will falsely alter the reading obtained. For this 
reason, tonometry-the recording of intraocular 
pressure-is essential in conjunction with ophthal-
modynamometry. Despite great care in technique, 
false negative readings abound. Our experience has 
suggested that significant ophthalmodynamometric 
asymmetry indicates extreme stenosis, if not actual 
occlusion, of the symptomatic internal carotid ar-
tery. Ophthalmodynamometry plays a definite, 
though limited, role in the diagnosis of atheroscle-
rotic cervical internal carotid disease. With the value 
of ODM's in perspective, we continue to use them 
routinely. 
A discussion of amaurosis fugax is not com-
plete without a brief review of the differential diag-
nosis. Although almost all transient monocular visual 
loss is due to internal carotid arterial disease, there 
are other considerations which include temporal 
arteritis, migraine and migraine equivalents, glau-
coma, papilledema, Raynaud's disease, and other 
emboli. It is seldom difficult to identify these addi-
tional sources of transient monocular visual loss 
if they are appropriately sought. 
Amaurosis fugax, although the hallmark of 
occlusive internal carotid disease and certainly its 
most common symptomatic neuro-ophthalmic pre-
sentation, is by no means the only eye manifesta-
tion encountered in internal carotid vascular disease. 
The following discussion will describe a number of 
less commonly recognized clinical syndromes caused 
by occlusive internal carotid disease. 
Retinal stroke, although commonly an integral 
aspect of the syndrome of amaurosis fugax, cer-
tainly occurs in the absence of prior symptomatic 
transient monocular visual loss; there can be little 
doubt that the occurrence strongly suggests athero-
sclerotic disease of the cervical internal carotid 
artery. The work of Lubow and associates at Ohio 
State in 1972 has shown, angiographically, a 95% 
incidence of carotid bifurcation disease in patients 
having retinal strokes as compared to asymptomatic 
age-matched controls in which angiography demon-
strated a 25 % incidence of bifurcation abnormal-
ities. What do re.tinal strokes consist of? They 
consist of occlusive disease of the retina, previously 
relegated to ophthalmic practice. It has become ap-
parent, however, that many "retinal strokes" are 
of embolic origin and manifest cholesterol plaques 
exactly like those seen in amaurosis fugax. 
Central retinal artery and artery branch oc-
clusions, as well as more distal cholesterol emboli, 
producing peripheral defects frequently unappreci-
ated by the patient, constitute the retinal stroke. 
Their clinical manifestation is abrupt, usually pain-
less, persistent monocular visual loss. Blindness and 
optic atrophy frequently follow retinal strokes. In 
our brief historical review, one may recall Gowers' 
allusion to ipsilateral optic atrophy and blindness as-
sociated with contralateral hemiplegia. Carotid dis-
ease is obviously likely with this association. What 
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must not be forgotten is that isolated blindness and 
optic atrophy may also reflect cervical internal ca-
rotid disease. Other funduscopic alterations causally 
related to cervical or extracranial internal carotid 
disease occur. It is not commonly recognized that 
ipsilateral carotid occlusive disease may serve to pre-
vent the expression of both hypertensive and diabetic 
retinopathy. When a patient is seen with remarkably 
asymmetric hypertensive or diabetic retinopathy, con-
sideration of the possible presence of occlusive in-
ternal carotid disease should follow. 
Ischemic retinopathy, recognized as evidence 
of chronic retinal ischemia by Kearns and Hollen-
horst in 1963, is a syndrome consisting of a retinal 
picture similar to diabetic retinopathy with dilated 
veins, some resultant blot hemorrhages and micro-
aneurysms, low ophthalmodynamometric values, and 
at times, severe orbital pain. Ischemic retinopathy 
can be differentiated from diabetic retinopathy by the 
fact that it is unilateral and that there is no biochemi-
cal evidence of diabetes mellitus. Obviously, diabetes 
and the Kearns ischemic retinopathy may coexist. 
The significance of ischemic retinopathy is its re-
flection of severe impairment of internal carotid 
as well as collateral circulation to the eye and 
orbit. Not uncommonly, the major trunks from the 
aortic arch are the site of the vascular occlusion. 
There are three additional presentations of 
eye signs reflecting occlusive vascular disease which 
generally indicate, as does ischemic retinopathy, a 
more severe and diffuse vascular embarrassment of 
orbital as well as central retinal circulation. These 
are ischemic inflammation, "pseudouveitis"; ocular 
hypotony; and neovascular glaucoma. 
Ocular inflammation resembling uveitis may 
result from chronic ocular ischemia secondary to 
diffuse occlusive vascular disease, involving not only 
the internal carotid but the collateral channels as 
well. This syndrome is characterized by dilatation 
of episcleral veins, a turbid anterior chamber, iris 
synechiae, corneal precipitates, and edema. On 
occasion, vitreous hemorrhage may occur and 
cataracts may rapidly develop. 
In circumstances where acute reduction of 
orbital blood flow affects more specifically the 
ciliary body, reduced production of aqueous humor 
results leading to ocular hypotony and potentially 
phthisis bulbi. 
Chronic ischemia in the eye is also a stimulus 
to new vessel production. Prolonged reduction of 
orbital blood flow may result in proliferation of 
neovascular tissue on the surface and angle of the 
iris . This will often culminate in occlusion of the 
anterior chamber angle and a malignant form of 
secondary glaucoma referred to as neovascular or 
hemorrhagic glaucoma. 
It is obvious that the last three syndromes 
reflecting eye involvement, secondary not simply 
to carotid stenosis but most certainly to more severe 
carotid occlusive disease, as well as occlusive disease 
of the usual orbital collateral channels, may occur 
either in sequence or in combination. Their inci-
dence in reality is quite low. Ischemic retinopathy, 
a less severe manifestation of the same process, is 
reported in only 5 % of unilateral carotid occlusions. 
It is wise, however, to realize that eye signs other 
than simple transient or permanent monocular visual 
loss may point to disease of the cervical carotid 
vessels . 
In conclusion, one should mention the occur-
rence of unilateral Homer's syndrome in a not 
insignificant number of unilateral internal carotid 
occlusions. This quite likely represents involvement 
by edema and ischemia of the carotid sympathetic 
plexus in the adventitia. 
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